Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this trial involving women with symptomatic fibroids who were planning to undergo surgery, treatment with the selective progesterone-receptor modulator ulipristal acetate was effective in controlling excessive bleeding and reducing fibroid size at 13 weeks.
Uterine leiomyomas, or fibroids, are benign, hormone-sensitive, smooth-muscle tumors t...
Alternative Titles
Full title
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_919957250
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_919957250
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1103182
